Close Menu

NEW YORK (GenomeWeb) – Gyros Protein Technologies has signed a distribution agreement with Euro Diagnostica giving GPT's customers in Europe and North America direct access to Euro Diagnostica's iLite assay-ready cell lines.

The iLite technology is based upon a reporter gene assay format that is modified and adapted for applications through the whole drug development cycle, as well as for monitoring of biological drugs.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.